Clinical Trial Update: Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in Korea evaluating treatment for pediatric patients with very high-risk acute lymphoblastic leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Hyoung Jin Kang | Conditions: Acute Lymphoblastic Leukemia, Pediatric | Phase 2 | Status: RECRUITING